EMCDDA Home
  • EN
Search

Table TDI-2. Clients entering treatment and reporting treatment units, 1998–2011

Part (iv) Types of reporting treatment unit by country

CountryTypes of units covered in the data
BelgiumOUT+INP+LTS
BulgariaOUT+INP
Czech RepublicUp to 1998 OUT+LTA; from 1999 to 2004 OUT+INP+LTA+PRIS; since 2005:OUT+INP+LTA
DenmarkOUT+INP (in 2006: OUT+INP+OTH)
GermanyUp to 2004 OUT+GPs; 2005 AND 2006: OUT+INP; 2007, since 2008: OUTP+INP+LTA+PRIS
EstoniaOTH: Estonia we cannot separate in- and out-patient centres, because they provide both type of treatment.
Ireland(1)1997: OUT+INP+LTA; 1998: OUT+INP+LTA+GP; 1999: OUT+INP+LTA+GP+PRIS; 2000:OUT+INP+LTA+GP; 2001-2003,2005: OUT+INP+LTA; 2006-2007:OUT+INP+LTA+GPs; since 2008: OUT+INP+LTA+GPs+PRIS
GreeceUp to 1999 OUT+INP; since 2000: OUT+INP+LTA
Spain(2)OUTP+PRIS
FranceUp to 2004: OUT+INP+PRIS; 2005: OUT; since 2006: OUT+INP+PRIS
ItalyOUT
Cyprus2001,2002: OUT; 2003:OUT+INP; 2004: OUT+INP+PRIS; 2005: OUT+INP; since 2006: OUT+INP+PRIS (in 2008: OUT+INP).
Latvia(3)2002-2004: OUT; since 2005: OUT+INP; (in 2009 OUT)
Lithuania2002-2005: INP+OUT; since 2006: OUT
Luxembourg(4)Up to 2003 OUT+INP+LTA+PRIS; 2004: OUT+INP+PRIS; 2005-2006: OUT+INP+OTH; 2007, 2008: OUTP+INP; 2009 INP+PRIS+OTH; 2010: OUT+INP+LTA+OTH
Hungary(5)OUT+INP; 2008: OUTP+INP+LTA+PRIS+OTH; Since 2009:OUTP+INP+LTA+PRIS.
Malta(6)OUT; Since 2009: OUT+INP+LTA+PRIS
Netherlands(7)OUT+LTA; since 2008: OUT+INP+LTA
Austria(8)Up to 2005: OUT+GP+PRIS (only units notifying substitution treatment); since 2006: OUT+INP
Poland(9)INP 2008/2009: INP+OUT (TDI pilot project) + INP (IPiN data collection system)
PortugalOUT
RomaniaUp to 2006: INP (OUT units are sometimes organised within INP centres); 2007, 2008: OUTP+INP, Since 2009: OUTP+INP+PRIS
SloveniaOUT; from 2003 to 2005:OUT+PRIS
SlovakiaUp to 1999 OUT+INP; since 2000: OUT+INP+PRIS
FinlandIn 1996 OUT+INP; from 1998 to 2002: OUT+INP+PRIS; 2003-2004: OUT+INP+PRIS+GP+LTA; 2005: OUT+INP+PRIS+LTA; 2006: OUT+INP; 2007: OUT+INP+LTA+PRIS; since 2008: OUT+INP
Sweden(10)Up to 2002: OUT+INP+PRIS; 2003: OUT+INP; 2004:OUT+INP+ combined Outpatient-Inpatient in methadone treatment (OTH); Since 2005: OUT+INP+PRIS
United KingdomOUT+INP+GP
CroatiaOUTP+INP
TurkeyINP
NorwayOUTP+INP All treatments
 

Notes:

The following acronyms are used to abbreviate treatment unit type: OUT = outpatient treatment centres; INP = inpatient treatment centres; LTA = low-threshold agencies; PRIS = treatment units in prison; GP = general practitioners; OTH = other treatment units.

(1) Low-threshold methadone maintenance and crisis counselling.

(2) Since 2004: OUTP AND PRIS data together.

(3) Outpatient centres data covers only new clients.

(4) 2004 OTHER refers to Specialised drug unit of judicial police (SPJ).

(5) 2007 data refers to OUTP AND INP data together.

(6) Outpatient, inpatient treatment centres, low-threshold agencies, units in prison and dual-diagnosis unit of psychiatric hospital together.

(7) OUTP AND LTA data together; 2008: OUT and LTA and INP data together.

(8) In 2006 the DOKLI data collection system was implemented.

(9) For 2008 and 2009 data. Numbers presented in tables in scope of inpatient data are sum of data collected by two separated systems (TDI pilot project and Institute of Psychiatry and Neurology (IPiN) system). There is an overlap between the systems in inpatient data and due to that double counting is not eliminated between systems. Double counting is eliminated independently in each data collection systems (TDI pilot project and IPiN systems).The system provided by Institute of Psychiatry and Neurology covers all psychiatric facilities including wards in hospitals, psychiatric hospitals and inpatient rehabilitation treatment facilities. In the majority of these facilities only few or no drug users were treated. Main data comes from the rehabilitation centres specialised in drug treatment. Caution should be made when interpreting.

(10) Most recent prisons treatment data do not cover new clients.

See also ‘General notes for interpreting data’ on the Explanatory notes and help page.

Sources:

Reitox national reports 2011 — Standard table 3 and 34, Table TDI.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013